[HTML][HTML] Guidelines for the diagnosis and treatment of malignant pleural mesothelioma
N Van Zandwijk, C Clarke, D Henderson… - Journal of thoracic …, 2013 - ncbi.nlm.nih.gov
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
[HTML][HTML] Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Malignant mesothelioma (MM) is an aggressive and lethal cancer, mostly related to
inhalation of asbestos and erionite fibers. MM is associated with poor prognosis, because of …
inhalation of asbestos and erionite fibers. MM is associated with poor prognosis, because of …
[HTML][HTML] A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular …
Estimated glomerular filtration rate (eGFR) impacts the concentration of plasma biomarkers
confounding biomarker association studies of eGFR with reverse causation. To identify …
confounding biomarker association studies of eGFR with reverse causation. To identify …
[HTML][HTML] Malignant mesothelioma biomarkers: from discovery to use in clinical practice for diagnosis, monitoring, screening, and treatment
J Creaney, BWS Robinson - Chest, 2017 - Elsevier
Malignant pleural mesothelioma is a highly aggressive tumor associated with asbestos
exposure. There are few effective treatment options for mesothelioma, and patients have a …
exposure. There are few effective treatment options for mesothelioma, and patients have a …
Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma
J Creaney, IM Dick, A Segal, AW Musk, BWS Robinson - Lung Cancer, 2013 - Elsevier
Background Malignant mesothelioma (MM), a primarily asbestos-induced tumour, has a
poor prognosis, with over-all 5-year survival less than 5%. Tumour biomarkers are being …
poor prognosis, with over-all 5-year survival less than 5%. Tumour biomarkers are being …
Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation
Fluoro-edenite (FE) is a silicate mineral identified in the lava products of Monte Calvario
from stone quarries located in the southeast of Biancavilla, a small city of the Etnean …
from stone quarries located in the southeast of Biancavilla, a small city of the Etnean …
Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin–a case-control comparison nested into a prospective cohort of asbestos-exposed …
G Johnen, K Burek, I Raiko, K Wichert, B Pesch… - Scientific reports, 2018 - nature.com
Malignant mesothelioma (MM) is strongly associated with a previous asbestos exposure. To
improve timely detection of MM in asbestos workers, better screening tools–like minimally …
improve timely detection of MM in asbestos workers, better screening tools–like minimally …
Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review
Abstract Fluoro‑edenite (FE), asbestiform fiber found in Biancavilla (Sicily, Italy), presents
various characteristics similar to the asbestos group, in particular two fibrous phases …
various characteristics similar to the asbestos group, in particular two fibrous phases …
Hitting the bull's-eye: mesothelin's role as a biomarker and therapeutic target for malignant pleural mesothelioma
Simple Summary Mesothelioma is a deadly disease with a dismal prognosis. Since its
discovery, mesothelin, a cell surface protein, has been a promising biomarker and …
discovery, mesothelin, a cell surface protein, has been a promising biomarker and …
Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis
R Gao, F Wang, Z Wang, Y Wu, L Xu, Y Qin, H Shi… - Medicine, 2019 - journals.lww.com
Background: Soluble mesothelin-related peptide (SMRP) is a widely studied tumor marker
for diagnosing malignant pleural mesothelioma (MPM). This study discussed the diagnostic …
for diagnosing malignant pleural mesothelioma (MPM). This study discussed the diagnostic …